Search research articles
Contact Us
Filters
Showing results (151-160 of 191) with videos related to
Page
of 20
Sort By:
The British Journal of Nutrition
|
August 2, 2012
Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45-75 years
Yu Wang, Xiaoying Li, Xianhui Qin, et al.
Circulation
|
March 17, 2010
Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials
Michael Böhm, Magnus Baumhäkel, Koon Teo, et al.
Journal of Environmental Management
|
December 23, 2025
Green manure and rice straw recycling: A triple-win for productivity, environmental sustainability and net ecosystem economic benefit
Nano Alemu Daba, Jing Huang, Md Ashraful Alam, et al.
Kidney International
|
January 25, 2013
Common genetic variants of the human uromodulin gene regulate transcription and predict plasma uric acid levels
Jia Han, Ying Liu, Fangwen Rao, et al.
JAMA
|
November 29, 2007
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction
Rafael Díaz, Abhinav Goyal, Shamir R Mehta, et al.
Environment International
|
April 18, 2024
Associations of perceived built environment characteristics using NEWS questionnaires with all-cause mortality and major cardiovascular diseases: The prospective urban rural epidemiology (PURE)-China study
Mengya Li, Yang Li, Zhiguang Liu, et al.
Journal of Hypertension
|
October 8, 2020
Associations of estimated 24-h urinary sodium excretion with mortality and cardiovascular events in Chinese adults: a prospective cohort study
Xiaoyun Liu, Yinxiao Bai, Sidong Li, et al.
Circulation
|
September 23, 2009
Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease
Paolo Verdecchia, Peter Sleight, Giuseppe Mancia, et al.
Journal of Hypertension
|
February 8, 2017
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials
Emily R Atkins, Yoichiro Hirakawa, Abdul Salam, et al.
American Heart Journal
|
September 1, 2014
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Shinya Goto, Jun Zhu, Lisheng Liu, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 191) with videos related to
Sort By:
Page
of 20
The British Journal of Nutrition
|
August 2, 2012
Prevalence of hyperhomocysteinaemia and its major determinants in rural Chinese hypertensive patients aged 45-75 years
Yu Wang, Xiaoying Li, Xianhui Qin, et al.
Circulation
|
March 17, 2010
Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials
Michael Böhm, Magnus Baumhäkel, Koon Teo, et al.
Journal of Environmental Management
|
December 23, 2025
Green manure and rice straw recycling: A triple-win for productivity, environmental sustainability and net ecosystem economic benefit
Nano Alemu Daba, Jing Huang, Md Ashraful Alam, et al.
Kidney International
|
January 25, 2013
Common genetic variants of the human uromodulin gene regulate transcription and predict plasma uric acid levels
Jia Han, Ying Liu, Fangwen Rao, et al.
JAMA
|
November 29, 2007
Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction
Rafael Díaz, Abhinav Goyal, Shamir R Mehta, et al.
Environment International
|
April 18, 2024
Associations of perceived built environment characteristics using NEWS questionnaires with all-cause mortality and major cardiovascular diseases: The prospective urban rural epidemiology (PURE)-China study
Mengya Li, Yang Li, Zhiguang Liu, et al.
Journal of Hypertension
|
October 8, 2020
Associations of estimated 24-h urinary sodium excretion with mortality and cardiovascular events in Chinese adults: a prospective cohort study
Xiaoyun Liu, Yinxiao Bai, Sidong Li, et al.
Circulation
|
September 23, 2009
Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease
Paolo Verdecchia, Peter Sleight, Giuseppe Mancia, et al.
Journal of Hypertension
|
February 8, 2017
Side effects and tolerability of combination blood pressure lowering according to blood pressure levels: an analysis of the PROGRESS and ADVANCE trials
Emily R Atkins, Yoichiro Hirakawa, Abdul Salam, et al.
American Heart Journal
|
September 1, 2014
Efficacy and safety of apixaban compared with warfarin for stroke prevention in patients with atrial fibrillation from East Asia: a subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
Shinya Goto, Jun Zhu, Lisheng Liu, et al.
Page
of 20